Clinical Trials Logo

Alcohol Withdrawal Syndrome clinical trials

View clinical trials related to Alcohol Withdrawal Syndrome.

Filter by:

NCT ID: NCT01637415 Completed - Clinical trials for Alcohol Withdrawal Syndrome

The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS)

PAWSS
Start date: May 2012
Phase: N/A
Study type: Observational

Although there are several tools that can be used to evaluate the severity of ongoing alcohol withdrawal syndrome (AWS), there is no available tool that can predict which patients are at risk for developing AWS at the time admission, before the patient has developed AWS. Unfortunately, there are severe symptoms of alcohol withdrawal (e.g., seizures) which may develop early in the hospitalization, and before the development of other systemic symptoms which may warn medical personnel of the possibility of impeding alcohol withdrawal (e.g., autonomic instability, delirium). The goal of this study is to evaluate the psychometric properties (e.g., predictive validity) of a new tool, the Prediction of Alcohol Withdrawal Severity Scale (PAWSS), on identifying which patients are at risk for developing complicated AWS (i.e., seizures, hallucinosis, delirium tremens) among hospitalized, medically ill patients.

NCT ID: NCT00249366 Completed - Clinical trials for Alcohol Withdrawal Syndrome

Treatment of Alcohol Withdrawal in Hospital Patients

Start date: April 2001
Phase: Phase 4
Study type: Interventional

The purpose of this study is to test how tolerable and effective lorazepam is when used to treat alcohol withdrawal in hospital patients at risk for alcohol withdrawal.

NCT ID: NCT00146471 Completed - Clinical trials for Alcohol Withdrawal Syndrome

Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome

Start date: January 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of levetiracetam for treating alcohol withdrawal syndrome (AWS) in inpatients (vs. placebo). The primary come-out parameter is the reduction of the total needed amount of diazepam for add-on treatment of acute alcohol withdrawal symptoms. The secondary come-out parameter are - safety criteria (AE) - reduction of alcohol withdrawal score over the days.